PL3274339T3 - Sposób wytwarzania chlorowodorków 2- (homo)-piperazyno-1,3-benzotiazyn-4-onu - Google Patents
Sposób wytwarzania chlorowodorków 2- (homo)-piperazyno-1,3-benzotiazyn-4-onuInfo
- Publication number
- PL3274339T3 PL3274339T3 PL16711296T PL16711296T PL3274339T3 PL 3274339 T3 PL3274339 T3 PL 3274339T3 PL 16711296 T PL16711296 T PL 16711296T PL 16711296 T PL16711296 T PL 16711296T PL 3274339 T3 PL3274339 T3 PL 3274339T3
- Authority
- PL
- Poland
- Prior art keywords
- benzothiazin
- onu
- homo
- piperazine
- making
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
- C07D279/08—1,3-Thiazines; Hydrogenated 1,3-thiazines condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15160267.9A EP3072889A1 (en) | 2015-03-23 | 2015-03-23 | 2-Homopiperazine-1-yl-4H-1,3-benzothiazine-4-one derivatives and process for the preparation of 2-(homo)piperazine 1,3-benzothiazine-4-one hydrochlorides |
| PCT/EP2016/056371 WO2016151011A1 (en) | 2015-03-23 | 2016-03-23 | 2-homopiperazine-1-yl-4h-1,3-benzothiazine-4-one derivatives and process for the preparation of 2- (homo)piperazine 1,3-benzothiazine-4-one hydrochlorides |
| EP16711296.0A EP3274339B1 (en) | 2015-03-23 | 2016-03-23 | Process for the preparation of 2- (homo)piperazine 1,3-benzothiazine-4-one hydrochlorides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3274339T3 true PL3274339T3 (pl) | 2022-03-07 |
Family
ID=52780412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16711296T PL3274339T3 (pl) | 2015-03-23 | 2016-03-23 | Sposób wytwarzania chlorowodorków 2- (homo)-piperazyno-1,3-benzotiazyn-4-onu |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US10160754B2 (pl) |
| EP (3) | EP3072889A1 (pl) |
| CN (1) | CN107567439B (pl) |
| CA (1) | CA2980653A1 (pl) |
| EA (2) | EA202091353A1 (pl) |
| ES (1) | ES2905453T3 (pl) |
| GE (3) | GEAP202014609A (pl) |
| PL (1) | PL3274339T3 (pl) |
| UA (1) | UA123724C2 (pl) |
| WO (1) | WO2016151011A1 (pl) |
| ZA (1) | ZA202401526B (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3072889A1 (en) | 2015-03-23 | 2016-09-28 | Ecole Polytechnique Federale De Lausanne (Epfl) | 2-Homopiperazine-1-yl-4H-1,3-benzothiazine-4-one derivatives and process for the preparation of 2-(homo)piperazine 1,3-benzothiazine-4-one hydrochlorides |
| CN108929329B (zh) * | 2017-05-24 | 2020-12-11 | 中国医学科学院药物研究所 | 2-氮杂环-5-三氟甲基-8-硝基苯并(硫代)吡喃-4-酮类化合物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0621693B8 (pt) | 2006-05-24 | 2021-05-25 | Leibniz Insititute For Natural Product Res And Infection Biology E V Hans Knoell Institut Hki | compostos derivados de benzotiazinona, composição farmacêutica, e seu uso como agentes antibacterianos |
| WO2009001068A1 (en) | 2007-06-22 | 2008-12-31 | Cadbury Holdings Limited | Reduced fat chocolate |
| EP2020406A1 (en) * | 2007-07-16 | 2009-02-04 | Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e.V. Hans-Knöll-Institut | New antimicrobial compounds, their synthesis and their use for treatment of mammalian infection |
| JP6061346B2 (ja) * | 2010-11-19 | 2017-01-18 | エコール ポリテクニーク フェデラル ドゥ ローザンヌ （イーピーエフエル） | ２−ピペラジン−１−イル−４ｈ−１，３−ベンゾチアジン−４−オン誘導体、および哺乳類の感染症治療へのその使用 |
| EP2468746A1 (en) * | 2010-12-23 | 2012-06-27 | The University of Queensland | Benzothiazinone compounds and their use as anti-tuberculosis agents |
| CN103508980B (zh) * | 2012-06-14 | 2016-07-06 | 四川大学 | 苯并噻嗪-4-酮衍生物及其制备方法和用途 |
| EP3072889A1 (en) | 2015-03-23 | 2016-09-28 | Ecole Polytechnique Federale De Lausanne (Epfl) | 2-Homopiperazine-1-yl-4H-1,3-benzothiazine-4-one derivatives and process for the preparation of 2-(homo)piperazine 1,3-benzothiazine-4-one hydrochlorides |
| CN105669664B (zh) * | 2016-02-19 | 2019-05-10 | 浙江司太立制药股份有限公司 | 含有碱性氮杂环片段的苯并噻嗪-4-酮类化合物及其制备方法 |
-
2015
- 2015-03-23 EP EP15160267.9A patent/EP3072889A1/en not_active Withdrawn
-
2016
- 2016-03-23 UA UAA201710145A patent/UA123724C2/uk unknown
- 2016-03-23 WO PCT/EP2016/056371 patent/WO2016151011A1/en not_active Ceased
- 2016-03-23 EA EA202091353A patent/EA202091353A1/ru unknown
- 2016-03-23 GE GEAP202014609A patent/GEAP202014609A/en unknown
- 2016-03-23 CN CN201680017268.3A patent/CN107567439B/zh not_active Expired - Fee Related
- 2016-03-23 PL PL16711296T patent/PL3274339T3/pl unknown
- 2016-03-23 ES ES16711296T patent/ES2905453T3/es active Active
- 2016-03-23 GE GEAP201614821A patent/GEP20217258B/en unknown
- 2016-03-23 EA EA201792095A patent/EA035946B1/ru unknown
- 2016-03-23 GE GEAP201614609A patent/GEP20207127B/en unknown
- 2016-03-23 EP EP21186636.3A patent/EP3919480A1/en active Pending
- 2016-03-23 CA CA2980653A patent/CA2980653A1/en active Pending
- 2016-03-23 EP EP16711296.0A patent/EP3274339B1/en active Active
- 2016-03-23 US US15/560,771 patent/US10160754B2/en active Active
-
2018
- 2018-11-13 US US16/189,743 patent/US10358442B2/en active Active
-
2024
- 2024-02-21 ZA ZA2024/01526A patent/ZA202401526B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016151011A1 (en) | 2016-09-29 |
| EP3072889A1 (en) | 2016-09-28 |
| CN107567439B (zh) | 2021-04-16 |
| ES2905453T3 (es) | 2022-04-08 |
| GEP20207127B (en) | 2020-06-25 |
| EP3274339A1 (en) | 2018-01-31 |
| CN107567439A (zh) | 2018-01-09 |
| EA035946B1 (ru) | 2020-09-04 |
| US10358442B2 (en) | 2019-07-23 |
| US10160754B2 (en) | 2018-12-25 |
| GEP20217258B (en) | 2021-05-25 |
| ZA202401526B (en) | 2025-04-30 |
| CA2980653A1 (en) | 2016-09-29 |
| US20180051016A1 (en) | 2018-02-22 |
| GEAP202014609A (en) | 2020-01-27 |
| US20190077798A1 (en) | 2019-03-14 |
| UA123724C2 (uk) | 2021-05-26 |
| EP3274339B1 (en) | 2021-10-13 |
| EA202091353A1 (ru) | 2020-08-19 |
| EP3919480A1 (en) | 2021-12-08 |
| EA201792095A1 (ru) | 2018-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2018000256A (es) | 3-oxo-2,6-difenil-2,3-dihidropiridazin-4-carboxamidas | |
| DK3283511T3 (da) | Modified collagen, methods of manufacture thereof | |
| LT3377488T (lt) | Heterocikliniai junginiai, kaip imunomoduliatoriai | |
| LT3371190T (lt) | Heterocikliniai junginiai, kaip pi3k-gama inhibitoriai | |
| EP3153053C0 (en) | Laceless shoe | |
| MA44474A (fr) | Nouveaux inhibiteurs de la ferroportine | |
| PL3325443T3 (pl) | Sposób otrzymywania pridopidyny | |
| HUE054784T2 (hu) | 5-klór-2-difluor-metoxifenil-pirazolopirimidin vegyületek, amelyek JAK-gátlók | |
| DK3254326T3 (da) | Elektrolytdannelsesfremgangsmåde | |
| DK3254325T3 (da) | Elektrolytdannelsesfremgangsmåde | |
| DK3209323T3 (da) | Forbedret koaguleringssammensætning | |
| DK3341479T3 (da) | LNA-G-Proces | |
| DK3134084T3 (da) | Fremgangsmåde til behandling af lungeadenokarcinom | |
| MA41127A (fr) | Chaussure auto-extensible | |
| EP3398470A4 (en) | SHOE | |
| FI20155728A7 (fi) | Menetelmä kiinteän ligniinin valmistamiseksi | |
| PL4140976T3 (pl) | Sposób wytwarzania HCFO-1233ZD | |
| HUE057118T2 (hu) | Folyamat | |
| EP3338584A4 (en) | FOOTWEAR | |
| PT3412648T (pt) | Método de fabrico de 1,1,3,3-tetracloropropeno | |
| DK3548473T3 (da) | HMF-fremstillingsfremgangsmåde | |
| DK3304451T3 (da) | Beslutningstagning | |
| EP3265120C0 (en) | PROCEDURE | |
| DK3298022T3 (da) | Nye annelerede phenoxyacetamider | |
| DK3368519T3 (da) | Hidtil ukendte, heterocykliske antiøstrogener |